Intuitive Surgical Inc. (ISRG) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
$448.76 +1.03% NASDAQ • Public Delayed / 60s Snapshot
Intuitive Surgical Inc. (ISRG) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C+ • HOLD / WATCH
Cap $155.56B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C+
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
WHALE OPTIONS TUG-OF-WAR:57% Call Buyers ($15.9M)
43% PutsMax Pain: $440.00
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)
How ISRG Turns Every Dollar of Sales Into Real Bottom-Line Profit
Free Cash Flow:$2.58B (25.6% FCF Margin)
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
■ Revenue■ Net Profit■ Free Cash Flow
FY23
Rev $7.12B
FY24
Rev $8.35B
FY25
Rev $10.06B
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $10.06B | 66% | 29.3% | $2.86B | $2.58B | 14.9% |
| FY 2024 | $8.35B | 67.5% | 28.1% | $2.32B | $2.04B | 12% |
| FY 2023 | $7.12B | 44% | 24.8% | $1.80B | $1.49B | 2.7% |
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ISRG)
- ✓Live walkthrough of ISRG's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
ISRG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.59%▲ ASCENDING CHANNEL
2026-10-30O $453.6H $453.6L $431.2C $432.0VOL 3.48M
RES: $463.4SUP: $362.9SMA50: $401.5SMA200: $433.1
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ISRG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
38.7%/yr Implied 5Y Growth
vs. +20.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ISRG today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
NVO → ISRG Confirmed Filing
Intuitive Surgical explicitly disclosed in its Form 10-K that US bariatric surgery procedure volumes on da Vinci robotic systems slowed as patients trialed GLP-1 weight-loss drugs prior to surgery.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ISRG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
ISRG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Intuitive Surgical Inc. (ISRG)?
In FY 2025 (10-K), ISRG converted $10.1B of revenue into a 66% gross margin, 29.3% operating margin, and $2.6B in free cash flow (25.6% FCF margin).